Philip Morris
The Effects of Environmental Tobacco Smoke Exposure on Lung Function in A Longitudinal Study of British Adults
Fields
- Author
- Carey, I.M.
- Cook, D.G.
- Strachan, D.P.
- Cook, D.G.
- Document File
- 2505585888/2505586502/D. Lee 1053 -
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- ABST, ABSTRACT
- Area
- BADSTUBER,ANDRE/OFFICE
- Named Organization
- Economic Social + Research Council
- Site
- E16
- Named Person
- Cox, B.D.
- Feyerabend, C.
- Jarvis, M.
- Feyerabend, C.
- Author (Organization)
- Epidemiology Resources
- St Georges Hospital Medical School
- Master ID
- 2505585973/6055
Related Documents:- 2505585973-5974 Untitled Document 2505585973/5974
- 2505585975-5980 "Smoking Cessation and Mortality Trends Among 118,000 Californians, 600000 - 970000" J E Enstrom and C W Heath Jr Epidemiology (990000), 10, 500-512
- 2505585981-5993 Smoking Cessation and Mortality Trends Among 118,000 Californians, 600000 - 970000
- 2505585994-5996 Variance and Dissent Dissent Rebuttal to the Paper by Enstrom
- 2505585997-5999 Response to Kuller's Dissent
- 2505586000-6001 Rejoinder to Enstrom's Response
- 2505586002-6004 Review 1069 "The Influence of Smoking on the Risk of Alzheimer's Disease" C Merchant Et Al Neurology (990000), 52, 1408 - 1412
- 2505586005-6009 The Influence of Smoking on the Risk of Alzheimer's Disease
- 2505586010-6012 Review 1070 "Arterial Endothelial Dysfunction Related to Passive Smoking Is Potentially Reversible in Healthy Young Adults" O T Raitakari Et Al Annals of Internal Medicine ( 990000), 130, 578 - 581
- 2505586013-6016 Arterial Endothelial Dysfunction Related to Passive Smoking Is Potentially Reversible in Healthy Young Adults
- 2505586017-6020 Review 1071 "Childhood Passive Smoking, Race, and Coronary Artery Disease Risk. The Mcv Twin Study" W B Moskowitz Et Al Arch Pediatr Adolesc Med (990000), 153, 446 - 453
- 2505586021-6028 Childhood Passive Smoking, Race, and Coronary Artery Disease Risk the Mcv Twin Study
- 2505586029-6031 Review 1072 "The Effects of Environmental Tobacco Smoke Exposure on Lung Function in A Longitudinal Study of British Adults" I M Carey Et Al Epidemiology (990000), 10, 319 - 326
- 2505586040-6042 "Maternal Cigarette Smoking and Invasive Meningococcal Disease: A Cohort Study Among Young Children in Metropolitan Atlanta, 890000 - 960000"
- 2505586043-6048 Maternal Cigarette Smoking and Invasive Meningococcal Disease: A Cohort Study Among Young Children in Metropolitan Atlanta, 890000 - 960000
- 2505586049-6050 "Parental Smoking and Infection with Helicobacter Pylori Among Preschool Children in Southern Germany"
- 2505586051-6055 Parental Smoking and Infection with Helicobacter Pylori Among Preschool Children in Southern Germany
- Litigation
- Feda/Produced
- Date Loaded
- 11 Sep 2002
- UCSF Legacy ID
- sqe19c00
Document Images
Epidemiology May 1999, Volume 10 Number 3
MALES NOT LIVING WITH A SMOKER (nA554)
8
6
14
Geome[rIc Mean = 0.723 nyJml
ETS, COTININE, AND VENTILATORY FUNGTiON 321
Is
16
4
FEMALES NOT LIVING A SMOKER (n=711)
CeomeMC Menu m 031'! o81m1
,,. A 95 k Con06ence Interval - (0.413.036"!)
,.j 95Y.ConpAen<eInlevNa(0.658,0.794)
C
6
C.
0 1 2 3 4 5 6 7 8 9 10 I l 12 13 0 1 2 3 4 5 6 7 8 9 10 11
Cetlnine (nqfmi) CuOniue (ng/mp
MALES LIVING VVITH A SMOKER (a=129)
a
2
a
. FEMALES LIVING WITH A SMOKER (n~29)
18
16
14
GmmetrlcMevn=2]64nyJm1 12 . GeometrleMenn=1534np/ed
95'AConfdenceInterval~(1.970,2.184 ~ 10 95%CnnOdenceln4rv.l-(Id38,1.158)
a 6
4
J
AL
2
0 1 2 3 4 5 6 7 8 9 10 11 12 13 0 1 1 3 4 5 6 9 8 9 10 11 12 33
. Cotlnine (ng/mt) Cotinlne (nglmq
FIGURE 1. Distribution of cotinine by gender and household ETS exposure at foIlowup (N = 1,623).
TABLE 1. Household Environmental Tobacco Smoke Exposure Rates and Cotinine Levels by Selected
Factors
Number % Living with a
Smoker at HALSI
Totals 1,623 30
Smoking sratua
Never-smoker
962
31
Ex-smoker 661 28
Sez
Male
683
26
Female ~ 940 . 33
Age group (years)
46-459 ~
585
397
t
28
33
60-73 301 23
on .
Wales ,
72
31
North 96 - 32
North West ~ 199 30
Yorkshi umbecside 134 36
Wesx M" )ands 148 32
East M
id
lsnds 148 24
_
g
Easr outFt Wlese
S
South East 131
366 26
33
Greater London 120 28
~ tlcand
ass 136 31
1 134 15
I
477 25
I
I N-m
M 35
V
1 206 36
V
Other 49 47
Parenral smokitig
None
222
21
Mother only 97 31
Father only 767 29
Both parents 520 36
History of respiratory illness
No
611
28
Yes 1,012 32
'HALS1 and HAIS2 = x<alth md Li(atyte smveys I and 2.
% Living with a
Smoker at HAIS2' Geometric Mean
CotiNne at I-3AIS2' 95% Confidence
Interval
22 0.76 .. 0.72-0.81
22 0.75 0.70-0.81
22 0.78 0.71-0.86
19 0.90 0.83-0.99
24 0.67 0.62-0.73
22 0.90 0.79-1.02
26 0.73 0.66-0.81
23 0.78 0.69-0.88
13 0.68 0.58-0.78
24 0.93 0.70-1.44
25 0.98 0.77-1.24
23 0.72 0.60-0.86
30 1.09 0.88-1.34
20 0.75 0.63-0.91
18 0.67 0.54-0.81
16 0.58 0.46-0.74
22 0.58 0.46-0.72
22 0.65 0.58-0.74
21 0.78 0.61-0.99
21 1.19 0.97-1.45
10 0.51 0.41-0.62
18 0.62 0.56-0.69
24 0.79 0.66-0.93
23
28 0.86
0.96 0.77-0.96
0.80-1.15
35 1.32 0.96-1.83
50 1.25 0.72-2.16
18 0.67 0.57-0.80
22 0.85 0.67-1.08
19 0.71 0.65-0.77
28 0.88 0.79-0.98
23 0.78 0.70-0.86
22 0.76 0.70-0.82

322 CAREY ET AL
TABLE 2. Cross-Sectional Effect on FEVi (in m1) of
Household Environmental Tobacco Smoke Exposure (Yes/
No) at Health and Lifestyle Surveys I and 2
Smoking Status All Subjects Males Females
HALS I
All subjects
Subjects expased/coral
489/1623
179/683
310/940
Mean adjusced difference in -4 -90 54
FEVI (ml)y
95% confidence limits
-57, 49
-190, l0
-5, 113
Never-smokers
Subjects exposed/roral
302/962
91/329
211/633
Mean adjusted diff'erence in 32 -69 78
FEVi (ml)
95% confidence limits
-37, 101
-210, 72
5,151
Ex-smokers
Subjects exposal)total
187/661
88/354
991307
Mean adjusced difference in -61 -125 -18
FEV, (m!)"
95% confidence limits
-141, 19
-256, 6
-122, 86
HALS2 -
All subjecrs
Subjects exposedltotal
358/1623
1291683
229/940
Mean adjusced difference in -5 -87 39
FEV. (ml)
95%confidertce limitt
-58, 48
-189, 15
-18, 76
Never-smokers
Subjects exposed/total
210/962
6I/329
149/633
Mean adjusted difference in 61 -2 80
FEV, (ml)
95%confidence Ifmits
-6, 128
-149, 145
9, 151
Ex-smokets
Subjects exposed/toral
148/661
68/354
80/307
Mean adjusted difference in -95 -155 -32
FEV, (ml)"
95% confidence limits
-183, -7
-298, -12
-132, 68
Di(f mnce In F5V, residaal (adjusted for social class, region, and packyears)
between exposcd and unexposad sabjea.
published studies of adult ETS, calculating a point esti-
mate based on a random-effects modelz' to take account
of the large heterogeneity between studies.
Results
D[STR[nll-RON OF COTLNINE
At HALS2, living with a smoker was associated with
higher cotinine levels for both males and females (Figure
1). Table 1 shows rhe determinants of reported house-
hoLd ETS exposure and cotinine level. Household ETS
exposure decreased between studies (from 30% to 22%).
At both studies females were more likely to be living
with a smoker, as were younger subjects and those of
tower social classes. There was ho notable variation
across regions or with past smoking status.
Cotinine levels were higher in males,despite fewer
men than women living with smokers. Trends for coti-
nine with age and social class were similar to those for
household ETS exposure, but there was variation across
regions, with the highest values seen in Scotland and
YorkshirefHumberside and Lowest seen in East Anglia
and the South West. Adjusting cotinine level for all
factors in the table did not remove the heterogeneity
within any of these regions. The geometric mean coti-
nine level for each of the 11 regions was also positively
correlated with both the regional prevalence of ETS
exposure in the home (Pearson's correlation coefficient,
Epidemiology May 1999, Volume 10 Number 3
E
4
Nv
i
<~
00

w
N
?
TABLE 5. Cross-Sectional Studies of Adult Environmental Tobacco Smoke on FEV.
Ex
- Effects on FEV;
First
Author Year of
Publication
Country Age
(years)
Numbert
Population Smokers
Included?# Exposure Used for ETS
Effecc Estimate
Beta§ Standard
Errodl
Main Pulmonary ResultsY
Schilling's 1977 United States Parents 252 Families in three U.S.
towns Yes Spouse smoked vs not Negative N/A No effect of spouse's smoking
status on FEVi in neversmokers
Whites 1980 United States Middle-aged 800 Recruits from a physical
fitness course in San
Diego, CA Yes Smokey environment
for 20 years vs not -5.5 1.5 Largest differences seen for FEFss_,s
and FEFts-as
Comstock° 1981 United States 20+ 418 Residents in Maryland No 1+ smokers in
household vs not Negative NJAz RR = 1.42 for males for FEV,
<80% of predicted
Kauffmannrs
39 1983 France 25-59 2,898 Seven French cities No Lives with a current
smoker vs not 0.55 0.9 Effect present in women age >40
years (stronger for FEFrsrs)
Jones 1983 United States 20-39 (F) 205 Community in Michigan Yes Smokers in household
vs nor Positive N/As OR = 0.76 between high FEV,
and low FEVi
Lebowitr30 1984 United States Parents 271 Sample of the Tucson area Yes Spouse smokes vs
not NJA N/A+t No effect of spouse's smoking
status
BranekreeP° 1985 Netherlands 40-b0 (F) 57 Rural subsample of a larger
population study Yes > 10 cigarettes/day at
home vs none -0.8 3.4 Larger effect seen for PEF with
present exposure; no relationship
with FEVi decline
Svendsen° 1987 United Smtes 35-57 (M) 676 Eighteen U.S. cities
(Multiple Risk Factor
Intervention Trial) No Wife smokes vs not -2.8 1.3 Effect of FEV, larger at baseline
and nor when summed over all
visits
Masin 1988 Canada 15-35 293 Recruits from schools and
banks in Montreal No Person-years
cumulative exposure Negative NJAx Regression coefficient strongest for
home exposure on FEFs in men
Mzsjedi'r 1989 Iran 18-65 288 Healthy hospital workers
and visitors in Tehran No ETS at home or work
vs none -2 1.5 Effects of exposure on FV~, FEV;,
and FEFr,-75 stronger in men
Kauffmann't 1989 United States 25-69 (F) 1,211 Five U.S. cities No Husband smokes vs
not Negative NJAx Very small effects of both FEV,
(negative) and FVC (positive)
Hole16 1989 Scotland 45-64 1,295 Two communities in West
Scotland No >15 us <15 cigarettes
per day by cohabitee -3.2 1.6 Comparison given for high w low
exposure; no difference between
low and none
Ng's 1993 Singapore 20-74 (F) 739 Population sample in
Singapore No >1 heavy smoker at
home vs none -3.8 1.7 Small effects of FEVi in all
subgroups
Xul' 1995 China 40-69 502 Residential area in Beijing No ETS at home or work
vs none -6.1 2.5 Reductions in both FEVi and FVC
that are dose dependent for
home exposure
Frette's 1996 United States 51-95 651 Southern California
communiry ' No Lived in household
with a regular
smoker vs not -2.5 1.8 Small reductions in FEVi and
FEFts,5 found with household
exposure
(M) or (F) indicates that only males or females were included in smdy.
T Number included in estimate calculation.
; Yes(No whether ewsmokesss included in estimate calcularion (we tried to use neversmokers wherever
possible).
§ Pacentage deficit in the exposed group (positive or ttegative indicaees that we were only able to
obtain direction of effect).
II Standard errors calculated wherever possible (in the case of Hole et u!° we assumed that the
lower 95% confidence limit was exactly 0 to derive id.
9 PEV = forced expimtory volusne; FEF = forced expiratay flow; RR e risk ratio; PEF = peak
expirsrnry flow; FVC = forced vital capaclry; subscript = seconds.
r Calculation of a standard error was not possible, bue the 95% confidence interval is known tu
contain 0 but of unknown width.
LE098990SZ ( (

The Effects of Environmental Tobacco Smoke
Exposure on Lung Function in a Longitudinal Study of
British Adults
lain M. Carey, Derek G. Cook, and David P. Strachan
Small effects of environmental tobacco smoke exposure on
lung function have been demonstrated in many studies of
children, but fewer studies have examined adults in this re-
spect. We examined these relations in a 7-year longitudinal
study of 1,623 British adults, age 18-73 years, who were
nonsmokers throughout. Outcome was measured by forced
expiratory volume in I second (FEVI) adjusted forsex, age, and
height. Exposure was assessed by asking subjects whether they
lived with a smoker (at both the initial and the follow-up
studies) and by salivary cotiNne measurements (follow-up
ty only). Cross-sectionally, subjects exposed at home
wed tiny FEVt deficits at both studies of -4 ml [95%
0 fidence limits (CL) = -31, 23] and -5 ml (95% CL =-32,
22), resiectivelp. Cotinine adjusted for potential confounders
showed a stmri,,~r association with FEV,, with the highest
quintile showing a-105-m1 deficit (95% CL =-174, -37) in
comparis,n with the lowest. Longitudinally, no clear relation
was appaicnt benrcen change in FEVr and average exposure or
change in cxpt*'ure. These resulta indicate that environmental
tobacco smokc is associated with small deficits in adult lung
function, .'onsisrrnrwith our meta-analysis estimate of a 2.7%
deficit in expes,el nonsmoking adults. The relations seen with
cotinine but n.rt with household exposure may reflect the
importance of exposure outside the home. (Epidemiology
1999110:319-326)
Keywords: adult, corfnine, environmental tobacco smoke, forced expiratory volmne, cohort study,
meta-analysis.
Exposure to environmental tobacco smoke (ETS) has
. been shown to be associated with poor respiratory health
in sevet: 1 studies of children." Our recent meta-analy-
sis of ETS exposure on lung function in children con-
cluded that maternal smoking is associated with cross-
sectional deficits in forced expiratory volume in I
second (FEVt) of 1-2%° at school age. Much of this
difference may be dur~to matemal smoking during preg-
nancy.
Fewer studies have assessed ETS exposure and lung
function in adults. These stuaies are inherently difficult
owing to the dominant effect of active smoking (past
and present) and the possibility of reporting bias, which
m result in active smoker's being classified as "passive"
c Nevertheless, exploring the link between exposure
andlung-ftirtctionmay be informative, as small deficits
can be early indicators of chronic obstructive pulmonary
disease.s Two recent reviewss6 of adult studies concluded
that exposure to ETS was associaced with small deficits
Fivm rf.a Department ot Public Heabh Sciences. St Geurge's HoapiraL Medicsl
School, Lm.don, unircd Kingdam.
Addreas coneapwrdence m: Ivn Carey, Dcparmr<nc of Public Health Sciences.
St r3ewge'a Hmpinl Medical School, Crenmer Tenace, landon SW l7 ORE,
utc
Submitted July 22, 1998; final verslon accepted )snuary 6, 1999.
C 1999 by Epidemiology Raourccs tac
n in lung functioti 7-1s All studies used questionnaire mea-
sures to nteasure exposure- The evidence for longitudinal
effects is even weaker, on the basis of two studies finding
small effects on FEVI decline.lo'9
In this paper, we use longitudinal data from a national
survey of Bririsli adults to assess both cross-sectional and
longitudinal effects of ETS exposure in the home on
FEVt. We also use salivary cotinine measurements that
were taken at follow-up to assess recent ETS exposure
more precisely.
Subject, and Methods
THE I"IEALTH AND LIFESr1'LE SVRvEy
The first health and lifestyle survey (HAI:SI) consisted
of a random sample of 9,003 adults resident in England,
Scotland, or Wales, who were interviewed and measured
initially during 1984 and 1985. A follow-up study
(HALSZ) 7 years lacer interviewed and remeasured
5,352 (59.4%) members of the original sample. Further
details of the sample selection and data collection for
both studies have been published.ZOzt
The structure and method used in both surveys were
similar. First, an interview carried out in the respon-
dent's home addressed a wide range of information,
including socioeconomic status, self-reported health, di-
etary habits, and smoking history. Subjects were classed
as having ever smoked if they reported ever having
"smoked at least one cigarette a day for as long as 6
319

320 CAREY ET AL
months." ETS exposure was assessed by positive re-
sponses to the question, "Does anybody else in this
household smoke regularlyt"; this was a question asked at
both studies. Parental smoking was assessed by asking, at
baseline, "Have either of your parents ever smoked?"
Individuals were assigned to a household socioeconomic
group on the basis of the 1980 Registrar General's clas-
sification.22 The interview was followed by a home visit
by a nurse who collected a saliva sample and carried out
physiological measurements, including height and respi-
ratory function.
SPIROMEiRY
Standing height was measured with a portable stadiom-
eter. FEVI was measured with an electric turbine spi-
rometer (Micro Medical Instruments, Rochester, En-
gland). Calibration of each instrument was carried out at
the start of each wave of data collection and rechecked
at the end by placing it in series with a Vitalograph
spirometer (Buckingham, England). Measurements were
discarded in the few cases in which significant calibm-
tion drift had occurred.
After suitable instructions and a practice attempt,
each subject performed three forced expiratory maneu-
vers. The maximum value of FEVi attained is used in the
analysis here. Subjects with an acute respiratory infec-
tion had their measurements discarded, as did any whose
tests were deemed unsatisfactory by the nurse.EO As pre-
viously noted?} there was probably a systematic under-
estimation of forced vital capacity (FVC) within
HALS1 and HALS2, so we do not present any analyses
of FVC here.
COTININE
Dental rolls were used to collect saliva for cotinine
measurements. Respondents were asked to place the roll
in their mouths for 3-5 minutes until it was saturated
with saliva, and the roll was then placed in a small
specimen tube. These were either dispatched immedi-
ately by first class mail to the laboratory or kept in a
domestic freezer until forwarded. Cotinine concentra-
tion was measured by gas-liquid chromatography as de-
scribed elsewhere.Z9
EXCLUSIONS
We restricted our sample to Caucasians who were be-
tween 18 and 73 years of age at the first survey (HALSl)
with satisfactory spirometric measurements at both ex-
aminations, who had not smoked between studies (and
were subsequently classed as either never-smokers or
ex-smokers), and who had salivary cotinine measure-
ments. Data were too sparse among subjects age 74 or
more years at entry. We also excluded subjects (N = 13)
with cotinine levels greater than 14.7 ng/ml (consistent
with active smokingzs) and those for whom change in
FEV, (AFEV) lay outside the middle 99% of the distri-
bution (N = 17). After these exclusions, we had 1,623
subjects for analysis.
Epidemiology May 1999, Volume 10 Number 3
STATISTICAL METHODS
We used a "two-step" approach to our regressions, which
was identical to a previous analysis on these data.L6 First,
we adjusted FEV/ and AFEV measurements (both in
(iters) for the effects of age (in years) and height (in
centimeters):.To do this adjustment, we used a set of
prediction equations that were based on the never-
smokers with no history of respiratory illness throughout
(246 males and 497 females). Cross-sectionally, these
were the following:
Males (1984):
FEVI =-2322 +(0.012 X age) + (0.036 X height)
-(0.000024 X age X heigtt)-[0.C0041 x(age)Z]
Females (1984):
FEV, =-2.779 + (0.051 X age) + (0.036 x height)
-(0.00030 x age x height)-[O.C0032 X(age)z]
Males (1991):
FEV, = -4.013 +(0.014 X age) + (0.048 X height)
-(0.00012 x age x height) - [0.00024 x(age)z]r
Females (1991): ~/
FEV, = -2.462 + (0.029 x age) + (0.036 X height)
-(0.00023 x age x height) -[0.00020 x(age)2]
Longitudinally, we used a model with annual change
in FEV, (i1FEV/a1AGE) as the dependent variable, as
some subjects had 6 or 8 years between studies. The
model contained terms for mean age (AGEM) and
height at first examination, which is compatible with
the form of the cross-sectional model with height as-
sumed constanr.Z6 The longitudinal equations were:
Males: AFEV/DAGE _ -204.6 - (0.578 x AGEM)
+ (1.164 x height)
Females: OFEV/GAGE = 70.16 - (0.618 X AGEM)
- (0.403 x height)
We used the regression coefficients from the above
equations to calculate a set of predicted values and
residuals (observed minus predicted values). The mean
residuals for FEV~ for the 1,623 subjects were -106 ml in ,~
1984 and -82 ml in 1991 (nonzero and negative, as th _e
model has-been extended to include ex-smokers). In the- longitudinal model, for the purposes of
presentation, we .
multiplied the residuals by 7 to represent the predicted
loss over the 7-year interval between examinations..
To look at the effects of ETS on lung function we
regressed the FEV, residuals on both the dichotomous
home ETS exposure variable and (natural) log cotinine
and the OFEV residuals on exposure profile (a four-
factor category representing all permutations of exposure
at baseline and follow-up) using the OLM procedure in SAS (SAS Institute, Cary, NC). We included the
fol-
lowing as potential confounding variables: social class
(six household socioeconomic groups plus an
`bther" category), region of residerice (nine English re-
gions, Scotland, and Wales) and pack-years (estimated
as the average consumption times years of smoking given
at baseline). We then carried out a meta-analysis of

Epidemiology May 1999. Volume 10 Number 3
WhSte
F---~'-~ i
+
Kauffmaun (Fr)
B
k
f
i i
i
i
l
i
rune
ree ~
~
Svendsen /---0--~
di i
Masje i
Hole i~---fl----i
~
N
g
~
x o~ ;
u .
Frette F-¢-`-1
Fizad K-1
Ravanm F-"-1
-12 -6 0 6 12
PercentDiRerence(FEV,) FIGURE 2. Meta-analysis of the effects of ETS on FEV,
in nonsmoking adsil[@. ,
home, such as a the workplace or public areas, may be of
importance in addition to home exposure as a source of
exposure to tobacco smoke. We have previously demon-
strated the importance of:, exposure outside the home in
-tennining cotinine levels in children?t This exposure
~rfiay explain why subjects who were not currently exposed
at home, but who had lived with a smoker 7 years ago, had
higher cotinine levels than those not exposed throughout.
Nondomestic exposure is also a likely explanation for males
having greater cotinine levels despite a smaller proportion
with current home exposure.
F.ELAT[ONS WfTH LUNG FUNCC[oN
There was no substantial effect on FEV, of living with a
smoker at either study, in contrast to the consistent reduc-
tion in FEV1 with increasing cotinine level at HALS2
(which persisted in never-smokets and in those not ex-
posed at home). The half-life of cotinine is 20 hours, and
thus it is largely a measure of exposure during the past 48
hours.r^ Possible reasons why we see a relation for FEV,
with cotinine and not with household ETS exposure could
be that (1) cotinine is a more precise measure, as it is able
ETS, COTININE, AND VENTILATORY FUNCTION 325
to quantify level of exposure; (2) recent exposure is most
influential in lowering FEV,; and (3) exposure from outside
the home is more important than domestic sources either as
a determinant of overall ETS exposure or in causing a
deficir in FEV,. It is likely that all three reasons have had
some influence in HALSl and HALS2.
Tredaniel et al suggested that, if ETS exposure causes
small airways dysfunction, theff-measurements that "de-
pend on total airway resistance and elastic recoil of the
lung," such as FEV, and FVC, will not pick up these
de$cits.6 Instead, mid- and end-forced expiratory.flow rates
(FEFz~75 and FEF7,85), which have been shown to produce
larger deficits in a meta-analysis of children's studies,° are
thought to be better for assessing small-ainvay dysfunction.
Unfortunately, these measurements were not made in
HALS1 and HALS2.
The inverse association between cotinine and lung func-
tion wass greater in ma[es and ex-smokers. The gender
difference may be attributable to level of exposure, as males
were seen to have much greater cotinine levels. The larger
deficits in ex-smokers, noted by Schilling et 47 may indi-
cate that some have continued to smoke intertnittentiy
during the follow-up. We excluded subjects with raised
cotinine levels consistent with regular active smoking to
minimize this problem, however. The deficits may also
represent lost lung function from their smoking years that
is not regained, but this would only bias our results if
ex-smokers had had greater cotinine levels or domestic
exposure rates, which they did not (Table 1).
Longitudinally, there was a weak relation between
changes in household ETS exposure and changes in
FEV, which suggests small benefits of others quittingg in
the home. There was little evidence of more rapid de-
cline in subjects exposed at both studies, arguing against
any cumulative effect of living with a smoker.
CHILDHOOD ExPOSURE AND EFFECTS
The role that ETS exposure during pregnancy and child-
hood plays in determining adult lung function is still
unresolved. We know that this exposure causes small
deficits in childhood FEV i,4 which may reflect impaired
lung growth. Whether this carries over to the subsequent
adult level and decline is unknown. Parental smoking as
recalled (retrospectively) by adults in HALSI and
HALS2 showed a weak positive relation with adult
FEVi. This finding implies that any long-term effect of
childhood exposure is subtle and difficult to detect in a
study of this size with such crude indicators of parental
smoking.
Our meta-analysis of adult studies indicated a deficit
in the range of 1.7-2.7% among passively exposed non-
smoking subjects, a result that is consistent with the
U.S. Environmental Protection Agency's conclusion of
a 2.5% deficit in those exposed to ETSJZ This result
compares with a reduction of 1.4% in a recent meca-
analysis of the effect of parental smoking on FEV i in
childhood.9
We conclude that the effects of ETS on lung function
in adults are likely to be similar in magnitude to effects

Epidemiology May 1999, Volume 10 Number 3 EI-S, COTININE, AND VENTILATORY SUNCTION 323
TABLE 4. Cotinine Level and Change in FEV, (AFEV) by Household En- ETS exposure did not appear to
influ-
vironmental Tobacco Smoke between Studies ence the rate of FEV, decline at alL;
Lives with Smoker at HALS2`
Lives wirh Smoker at I-IALSI" No Yes
No
Number
1038
96
Geometric mean cotinine at HALS2 (ng/ml) 0.57 1.15
95% confldence limits 0.53, 0.6Z 0-96, 1.37
Difference in AFEV (ml)t Baseline -43
95% confidence limits -114, 28
Yes
Number
227
26Z
Geometric mean codnine at HALS2 (ng/ml) 0.76 2.10
95% confidence limirs
Difference in AFEV (ml)f
95% confidence limits 0.65, 0.89
+14
-35, 63 1.83, 2.40
+25
-20, 70
' Health and Lifestyle Surveys I and 2.
Y DilF rence in dFEV between selccted ezpmed and nonexposed groups adjusted for.ocial cla.u, region,
and pack.years (all at baseline). ,
r = 0.52) and the regional prevalence of active smoking
calculated from all the HALSI data (r = 0.74).
I.ROSS-SEGTIONAL EFFECt3 OF ETS
Among all subjects, living with a smoker was associated
with tiny deficits in lung function at both studies (Table
2) of -4 ml [(95% confidence limits (CL) _-31, 231
and -5 ml (95% CL =-32, 22), respectively. Only
among male ex-smokers was there any suggestion of a
larger deficit in FEV, among the exposed group [-61 ml
(95% CL = -141, 19) and -95 m[ (95% CL = -183, -7)
at HALS1 and HALS2, respectively]. ,
Cotmine (measured at HALS2 only) showed a stronger
relation with FEV, (Table 3). There was a deficit of
-105 ml (95% CL =-174, -37 ml) between the top and
bottom quintiles of exposure: This deficit was not ex-
clusive to ex-smokers, as it was apparent among never-
smokers [top-bottom quintile deficit = -76 ml (95%
CL =-160, 8 ml): The effect appeared stronger in men,
as there was a 166-ml (5.3%) deficit in FEVI between
top and l5ottom quintiles in men compared with 68 ml
for women (2.8%). The magnitude of effect increased by restricting the analysis
~Gsubjecs (N = 1,265) with no reported household EIS
exposure at HALS2 (not shown). The top-bottotn quintile
deficit was -147 ml (95% CL = Z36, -57).
LONGITUDINAL EFFE(.`I5 OF ETS
Cotinine level (at follow-up) was related to home ETS
exposure profile over both studies (Table 4). Among
those exposed at HALS2, levels were higher if they had
also been exposed at HALS1. Similarly, among those
not reporting home ETS exposure at HALS2, cotinine
levels were higher if they had been exposed at HAL91.
These trends were seen in males and females separately.
There was no clear relation between change in expo-
sure and change in FEV, (Table 4)_ The "newly" ex-
posed subjects did show a greater fall in FEV, albeit
modest, than those who never lived with a smoker
throughout [-36 ml (95% CL =-114, 28). Persistent
those..living with a smoker at both
studies showed the smallest fall in lung
function between studies.
EFFECrs OF PA$ENFAL SMOKRJG
We looked at the effects of parental
smoking habit (none, mother only, fa-
ther only, and both) on current lung
function and found no evidence of a
negative relationship with FEVI. At
both studies, current nonsmokers
whose mothers had been smokers had
on average higher FEV, than those
whose mothers had not smoked, de-
spite their having higher cotinine lev-
els at HALS2. This difference was 64
ml (95% CL = 14 to 114) at HALS1,
falling to 47 ml (95% CL = 2 to 92) at HALS2, with the
decline of FEVI between studies being only weakly
related with maternal smoking [-25 ml (95% CL =
-58, 9].
MEPA-ANALYSIS OF ADULT STUD[ES OF ETS
Using the 21 studies included in two recent reviews of
the literature on ETS and adult lung function,s4 we
conducted a meta-analysis of the effect of ETS on adult
FEV, (Table 5 and Figure 2). Among 15 population
studies that looked at FEV, cross-sectionally,7-`&2sao
only 9 gave sufficient information to be included in our
calculations,atatl.ls.ls-is.zs and these were generally from the
studies that had found statistically positive results. Conse-
quently, our random-effects estimate of a -2.7% (95%
CL = -4.1%, -1.2%) deficit in FEV, is likely to be biased.
By estimating the standard error for the remaining six
studies from the existing ones, we can recalculate the
random-effects deficit on the conservative assumption that
on average the six excluded studies found no association.
The pooled random-effects estimace for the deficit in FEV,
is then -1.7% (95% CL = -2.8%, -0.6%).
Discussion
In this national longitudinal study of British adults, we
explored the relation between lung function and ETS,
assessed by whether each subject lived with a smoker
and also by measurement of salivary cotinine. Our results
indicate that any effect of ETS on FEV, is small, but is
stronger when cotinine is used as an index of exposure.
DETERMINAN15 OF ExPOsuRE
This is the first report to explore adult cotinine levels
among a national sample of nonsmokers in the United
Kingdom. We found marked variations between regions,
with the northern regions and Wales having the highest
levels. Although this variation was partly due to home
exposure, it was also strongly related to active smoking
prevalence in each region as calculated from all the
HAIS1 data. Thus, we believe that sources outside the

326 CAREY ET AL
seen in childhood and chat sources of exposure away
from the home are important determinants of this effect.
We found no evidence to link domestic ETS exposure
with more rapid tung function decline in adult life.
Acknowledgments
We thank the Economlc Social and Reseazch Council Data Archive for provid-
ing us with the dara, Brian D. Cox and the numerous research workers who
conducted both health and lifestyle aurveys, and Martin Jarvu and Colin Fey-
erabend for the cotinine assays.
References
1. Strachen DP, Cook DG. Healrh effecrs of passfve smoking. 1. Parental
smoking and lower respiratory illness In infancy and early childhood Thoraz
1997;52:905-914.
2. Cook DO, Srrachan DP. Health effccrs of pacsive smoking. 3. Parenml
smoking and prevalence of respimtory symptoms and esthma in school age
children.Thorax 1997;52:I081-1094.
3. Snachan DP, Cook DO. Health effects of passive smoking. 6. Parental
smoking artd childhood asthma: longitudinal and case.control studies. Tho-
rax 1998;531204-212.
4. Cook DG, Snachan DP, Carey IM. Parenmi smoking and spirometry in
childrem Thorax 1998;53:884-893.
5. Coulrzs DB. Passive smoking and the risk of adulr asthma and CDPD: an
update.Thorax 1998;53:381-387.
6. Tredaniel J, Boffetta P. Saracci R, Hhsch A. Exposure to environmental
robac<o smoke and ruk of lung cancen the epidemiological evidence (Re-
view). Eur Revpir J 1994;7:1877-1888.
7. Schilling RS, lztzi AD, Hui SI., Beck G), Schoenberg JB, Bouhuys A. Lung
function, respiratory disease, and smoking in familics. Am J Epidemlol
197706:274-283.
8. White JR. Froeb HF. Small-alrways dysfunction in nommokers chronically
exposed m tobacco smoke. N Engl J Med 1980;302:720-723.
9. Comsrock OW, Meyer MB, He6ing KJ, Tockman MS. Respimtory effects on
household exposures to tobacco smoke and gas cooking. Am Rev Resyir Dis
198L;124d43-148.
10. Bmnekreef B, Fucher P, Remijn B, Van DL Schouten J, Quanjer P. Indoor
air pollution and la effect on pulmonary function of adult non-smoking
women. Lll. Passive smoking and pulmonary function. Int J Epidemiol
1985;14:227-230.
11- Svendscn KH, Kuller LH, Martin M). Ockene JK. Effecrs of passive smoking
in the Multiple Risk Factor Inrervenrion Trial. Am J Epidemiol 1967:126:
783-795.
12. Masi MA, Hanley JA, Emat P, Becklake MR. Environmenral exposure to
cobacco smoke and lung function in young adults. Am Rev Respir D'u
1988:138:296-299-
13. Masjedi MR, KazemL H, Johmon DC. Effects of passlve smoking on the
pulmonary function of aduls. Thorex 1990;45:27-31.
14. Kauffmann F, Dzkcry DW, Speixr FE, Ferrts BC Jr. Respirarory symptoms
Epidemiology May 1999, Volume 10 Number 3
and lung function in relation to passive smoking: a compamtive smdy of
American and French women. Inc ] Epidemiol 1989;18:334-344-
15- Hole DJ, Cill;s CR, Chopra C, Hawthorne VM. Passive smoking and
cardiorespimmry health in z gcnenl population in the wessofScodand. BMJ
1989:299:423-427.
16. Ng 7P, Hui KP, Tan WG Respimmry symptoms and lung function effecte
of domaric exposure to tobzcco smoke znd cooking by gas in non-smoking
women in Singapore. J Epidemiol Commun Heafth L993;47.454-458.
17. Xu X, Li B. Expnsure-response relationship between passive smoking and
adult pulmonary function. Am ] Respir Crit Care Med 1995;151:41-46.
18. Frene C, Barrett-Csnnor E;Hlausen ]L. Effect of active and passive smoking
on venrilatory function in elderly men and women. Am J Epidemioi 1996;
143:757-765.
19. Jzzkkola MS, Jaakkola JJ. Becklake MR, En+st P. Panive smoking and
evolution of lung function in young adults: an B-year longitudinal study.
J Clin Epidemiol 1995;48d17-327.
20. Cox BD, Blaxter M. Buckle AL). Fenner NP, Golding JF, Gore M, Huppert
FA, Nickson ), Roth M, Stark J. Wadsworth MEJ, Whichelow MJ. The
Health and Lifeuyle Survey. London. The Hcafth Prornotion Research
Trust. 1987.
21. Cox BD, Huppcrt FA, Whichelow MJ- The Health and Lifesryle Survey:
Scven Years On. Aldershot. U.K.: Dartmouth Publishing. The Health Pro-
motion Research Trust, 1993.
22. Office of Population Censuses and Surveys. ClassiAcacion of O<cupacions
and Coding Index. London: Her Majesty's Stationary Offrce- Office of
Population Censuses and Surveys, 1980.
23. Semchan DP, Cox BD, Erainclioglu SW, Walters DE, Whichelow MJ.
Venrilsrory function and winter fresh fruit consumption in a mndom sample
of British adulrs Thorax 1991;46:624-629.
24. F<yerabend C, Rusreli MA. A rapid gae-liquid chromacographic method for ~°
the decenninacion of cotinine and nicocine in biological fluids. J Phacm
Pharmscol 1990;42:450-452.
25. McNeill AD, Jarvis MJ, West R, Russell MA, Bryanr A. Saliva cotlnine as
an indicator of cigarette smoking Ln adulescenu. Br 3 Addict 1987;82:1355-
1360.
26. Carey IM, Stra<han DP, Cook DO. The effeccs of changes in fresh fruit
consumption on ventLlatory function in healchy Britvh adulrs. Am J Respir
Crit Care Med 1998;158:728-733.
27. Hardy RJ, Thompson SO. A likelihood approach to mem-analysis with
mndom effects. Smt Med 1996;15:619-629.
28. Kaut7mmsn F, Tessier JF, Ortiol P. Adult passive smoking in the home
environmene a risk factor for chronic air(low limiwtion. Am J Epidemioi
L983;117d69-280.
29. ]ones JR, Higgins IT, Higgins MW. Keller JB. Effecrs of cooking fuels on
lung function in nonsmoking women. Arch Environ Health 1983:38:Z19-
222.
30. Lebowitt MD, Knudson RJ, Buaows B- Famify aggregation of puln»nary
function measuremenrs. Am Rev Rcspir D'u 1984;129:8-11.
31. Cook DO, Whincup PH, Jarviz MJ, Svachan DR Papawsra 0, Bryant A.
Passive exposura to tobacco smoke in children aged 5-7 years: individual,
family, and community facmrs. BMJ 1994;308:384-389.
32. US Envimnmental Pmecction Agency. Respiratory Health Effects of Passive
Smoking: L.ung Cancer and Other Disorders. Washington, DC. Office of
Research and Development, 1992.
